| BMS790052 |
|
| (CAS 1214735-16-6) |
 |
| Description： |
BMS-790052 is a first-in-class, highly-selective oral HCV NS5A inhibitor. NS5A is an essential component for hepatitis C virus (HCV) replication complex. BMS-790052 has broad genotype coverage and exhibits picomolar in vitro potency against genotypes 1a (EC50 50pm) and 1b (EC50 9pm). BMS-790052 produces a robust decline in HCV RNA (-3.6 logs after 48 hours from a single 100 mg) dosefollowing a single dose in patients chronically infected with HCV genotype 1.
|
| Product No. |
KT00213 |
| Product Name |
BMS790052 |
| Synonyms |
Daclatasvir |
| Formal Name |
|
| CAS Number |
1214735-16-6 |
| Molecular Formula |
C40H50N8O6 |
| Formula Weight |
738.88 |
| Formulation |
A crystalline solid |
| Purity |
98%min |
| Stability |
2 years |
| Storage |
-20°C |
| Shipping |
USD45 for Europe and USA. No shipping charge once amount reach USD500 |
| Quality Control |
HNMR,CNMR,LCMS,HPLC,IR,etc. |
| Price & Availability |
In Stock. Price Negotiated. |
|
| Related Products： |
E-64
AEBSF HCl
Leupeptin Hemisulfate
Danoprevir (ITMN-191)
VX-222 (VCH-222, Lomibuvir)
Telaprevir (VX-950)
MG-132
Bortezomib (PS-341)
Carfilzomib (PR-171)
ONX-0914 (PR-957)
|
|
